News & Events
Keep up to date with Isogenica’s latest news on collaborations, Press Releases, Events and VHH antibody resources.
Isogenica’s
Latest News
Isogenica is presenting at the 6th Annual MarketsandMarkets Biomarker and Companion Diagnostics Virtual Conference
Isogenica is excited to announce its attendance at the MarketsandMarkets Biomarker and Companion Diagnostics Conference, October 12-14 2021Isogenica's Associate Director of Discovery, Marion Cubitt,...
Isogenica is attending BIO Europe 2021
Isogenica is excited to announce its attendance at BIO-Europe Digital 2021.Isogenica's Director of Business Development Dr David Mead, and Associate Director of Marketing, Dr Mandeep Sehmi will be...
Isogenica Discovery on Target PDF Poster
Isogenica is excited to announce its attendance at Discovery on Target 2021 September 27-30thIsogenica's Associate Director of Antibody Alliances, Marion Cubitt, will be attending Discovery on...
Events
Isogenica are always looking to learn and connect at upcoming events and conferences.
Events
Resources
Due to their unique characteristics, VHH are promising candidates for a range of application areas including intracellular targeting and even across the Blood Brain Barrier (BBB). Discover all the benefits in using VHH in different applications.
CIS display: In vitro selection of peptides from libraries of protein–DNA complexes
PNAS published February 23, 2004. 101 (9) 2806-2810
The structure of myeloid cell-specific TNF inhibitors affects their biological properties
Webinars
Webinars are a great source for the latest activities at Isogenica. Hear all about the newest applications of VHH.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Isogenica’s
Newsletters
Catch up with Isogenica’s news and activies through the latest Newsletters.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.